van de Munckhof, A, Kammen, MSV
, Tatlisumak, T, Krzywicka, K, Aaron, S, Antochi, F, Arauz, A, Barboza, MA, Conforto, AB, Contreras, DG, Heldner, MR, Hernandez-Perez, M
, Hiltunen, S, Ji, X, Kam, W, Kleinig, TJ, Kristoffersen, ES, Leker, RR, Lemmens, R, Poli, S, Wasay, M, Wu, T, Yesilot, N, Chen, J, Cotelli, MS, Demeestere, J, Duan, J, Ergin, N, Freitas, TE, Gomes, A, Hertog, HMD, Lindgren, E
, Martinez-Majander, N, Metanis, I, Miraclin, A, Rani, LJ, Reddy, YM, Scutelnic, A, Shanmugasundaram, S, Wijngaard, IRVD, Gencdal, IY, van Eekelen, R, Vellema, J, Arnold, M, Neto, L, Middeldorp, S, Sousa, DAD, Jood, K
, Putaala, J, Ferro, JM & Coutinho, JM 2025, '
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study',
Lancet Neurology, vol. 24, no. 3, pp. 199-207.
https://doi.org/10.1016/S1474-4422(24)00519-2